Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Proof-of-concept pilot study of a single one-hour remifentanil infusion for persistent postsurgical pain
2015-004517-24Phase 4Completed
- Sponsor
- Klinik Ottakring
- Start
- Mar 2016
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of remifentanil in Persistent postsurgical pain (PPSP), sponsored by Klinik Ottakring. Primary endpoint: Pain intensity at 7 days after treatment. Started Mar 2016; status: completed.
02
Drugs
remifentanil
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on 2015-004517-24.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-004517-24.